ALNYLAM PHARMACEUTICALS, INC. Accrued Liabilities 2009-2025 | ALNY
What is accrued liabilities?
Accrued liabilities are expenses that have been incurred but not yet paid, such as wages, interest, and taxes payable.
What is ALNYLAM PHARMACEUTICALS, INC.'s current accrued liabilities?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual accrued liabilities for 2025 was $1.08B, a 36.10% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. accrued liabilities for the quarter ending December 31, 2025 was $1.08B.
What was ALNYLAM PHARMACEUTICALS, INC.'s accrued liabilities in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual accrued liabilities for 2024 was $793.7M, a 11.32% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s accrued liabilities in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual accrued liabilities for 2023 was $713.0M, a 30.72% increase from 2022.
What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year accrued liabilities CAGR?
ALNYLAM PHARMACEUTICALS, INC. accrued liabilities grew at a compound annual growth rate (CAGR) of 24.86% from FY2020 to FY2025, going from $355.9M to $1.08B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.08B | +36.1% | 10-K |
| FY2024 | $793.7M | +11.3% | 10-K |
| FY2023 | $713.0M | +30.7% | 10-K |
| FY2022 | $545.5M | +38.0% | 10-K |
| FY2021 | $395.2M | +11.0% | 10-K |
| FY2020 | $355.9M | +80.5% | 10-K |
| FY2019 | $197.2M | +74.9% | 10-K |
| FY2018 | $112.7M | +56.1% | 10-K |
| FY2017 | $72.2M | +71.4% | 10-K |
| FY2016 | $42.1M | +46.3% | 10-K |
| FY2015 | $28.8M | +21.6% | 10-K |
| FY2014 | $23.7M | +67.2% | 10-K |
| FY2013 | $14.2M | +22.5% | 10-K |
| FY2012 | $11.6M | -6.3% | 10-K |
| FY2011 | $12.3M | +11.0% | 10-K |
| FY2010 | $11.1M | +11.6% | 10-K |
| FY2009 | $10.0M | - | 10-K |